Organogenesis Holdings Inc.
ORGO
$4.85
$0.0250.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 50.25% | -373.17% | -82.59% | -156.77% | -264.66% |
| Total Depreciation and Amortization | 9.63% | 12.48% | 10.80% | -20.78% | -19.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -26.69% | 64.43% | 57.64% | 138.87% | 101.09% |
| Change in Net Operating Assets | -184.89% | -81.46% | -170.51% | -67.64% | 27.15% |
| Cash from Operations | -251.32% | -82.83% | -54.04% | -50.59% | 30.33% |
| Capital Expenditure | 1.57% | 39.89% | 58.82% | 68.47% | 62.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 1.57% | 39.89% | 58.82% | 68.47% | 62.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -889.57% | -1,022.50% | -1,207.64% | -29.05% | -71.04% |
| Issuance of Common Stock | 503.87% | 503.87% | 124,700.00% | -- | 546.43% |
| Repurchase of Common Stock | -2,221.45% | -2,266.32% | -7,904.50% | -252.55% | -251.80% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 492.42% | 509.90% | 602.03% | -39.01% | -82.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,827.76% | 30,807.25% | 2,935.59% | 57.60% | 104.13% |